3-吡咯烷-1-基-1-丁醇 | 158261-95-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 3-吡咯烷-1-基-1-丁醇
• 中文别名: 吡咯烷丁-1-醇；3-吡咯烷-1-基丁-1-醇
• 英文名称: 3-Pyrrolidino-1-butanol
• 英文别名: 3-pyrrolidino-butan-1-ol；3-pyrrolidin-1-yl-butan-1-ol；3-(Pyrrolidin-1-yl)butan-1-ol；3-pyrrolidin-1-ylbutan-1-ol
• CAS: 158261-95-1
• 化学式: C₈H₁₇NO
• 分子量: 143.229
• InChiKey: FKCMGWYAPOCAKE-UHFFFAOYSA-N

物化性质

• 沸点：
  114 °C(Press: 21 Torr)
• 密度：
  0.981±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P301+P312,P302+P352,P304+P340,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  3-吡咯烷-1-基-1-丁醇 在 氯化亚砜 作用下， 以 二氯甲烷 为溶剂， 以100%的产率得到1-(3-chloro-1-methyl-propyl)-pyrrolidine hydrochloride
  参考文献：
  名称：

  3- Or 4-monosubstituted phenol derivatives useful as H3 ligands

  摘要：

  这项发明涉及3-或4-单取代酚衍生物，以及用于制备、制备中间体、含有和使用这些衍生物的过程。所述的3-或4-单取代酚衍生物是H3配体，在许多疾病、紊乱和状况中非常有用，特别是炎症性、过敏性和呼吸系统疾病、紊乱和状况。

  公开号：

  EP1593679A1
• 作为产物：
  描述：

  Ethyl 3-pyrrolidinobutyrate 在 lithium aluminium tetrahydride 、 sodium hydroxide 、 水 作用下， 以 四氢呋喃 为溶剂， 反应 3.0h， 以73%的产率得到3-吡咯烷-1-基-1-丁醇
  参考文献：
  名称：

  3- Or 4-monosubstituted phenol derivatives useful as H3 ligands

  摘要：

  这项发明涉及3-或4-单取代酚衍生物，以及用于制备、制备中间体、含有和使用这些衍生物的过程。所述的3-或4-单取代酚衍生物是H3配体，在许多疾病、紊乱和状况中非常有用，特别是炎症性、过敏性和呼吸系统疾病、紊乱和状况。

  公开号：

  EP1593679A1

文献信息

• Fused ring 4-oxopyrimidine derivative
  申请人：Nagase Tsuyoshi

  公开号：US20050182045A1

  公开（公告）日：2005-08-18

  The present invention provides a compound represented by formula (I) below, or a pharmaceutically acceptable salt thereof, which, having histamine H3 receptor antagonist or inverse agonist activity, is useful in the prophylaxis or therapy of metabolic diseases, circulatory diseases, or nervous system diseases. [where, for example, Ar is a divalent group formed by eliminating two hydrogen atoms from benzene, X 1 is a nitrogen atom, sulfur atom or oxygen atom, R 1 is a 5- to 6-membered heteroaryl group, Ring A is a 5- to 6-membered heteroaryl ring, R 2 and R 3 are amino groups or alkylamino groups, and X 2 is represented by formula (II): (where R 4 and R 5 are lower alkyl groups, and n is an integer from 2 to 4).]

  本发明提供以下公式（I）所表示的化合物或其药学上可接受的盐，具有组织胺H3受体拮抗剂或逆激动剂活性，在代谢性疾病、循环系统疾病或神经系统疾病的预防或治疗中有用。【其中，例如，Ar是通过从苯中消除两个氢原子形成的二价基团，X1是氮原子、硫原子或氧原子，R1是5-至6-成员杂芳基团，环A是5-至6-成员杂芳基环，R2和R3是氨基或烷基氨基，X2由以下公式（II）表示：（其中R4和R5是较低烷基基团，n是从2到4的整数）。】
• 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands
  申请人：Bernardelli Patrick

  公开号：US20050267095A1

  公开（公告）日：2005-12-01

  The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol and thiophenol derivatives are H 3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

  本发明涉及公式(I)的3-或4-单取代苯酚和硫代苯酚衍生物，以及用于制备这些衍生物的中间体、含有这些衍生物的组合物和这些衍生物的用途的过程。所述的3-或4-单取代苯酚和硫代苯酚衍生物是H3配体，在许多疾病、失调和病况中特别有用，特别是在炎性、过敏和呼吸系统疾病、失调和病况中。
• 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
  申请人：Pfizer, Inc

  公开号：US07456164B2

  公开（公告）日：2008-11-25

  The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol and thiophenol derivatives are H3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

  本发明涉及式（I）的3或4-单取代苯酚和噻吩酚衍生物，以及用于制备、制备中间体、含有和使用此类衍生物的组合物的过程。所述的3或4-单取代苯酚和噻吩酚衍生物是H3配体，可用于许多疾病、障碍和病况，特别是炎症性、过敏性和呼吸系统疾病、障碍和病况。
• FUSED-RING 4-OXOPYRIMIDINE DERIVATIVE
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP1717230A1

  公开（公告）日：2006-11-02

  The present invention provides a compound represented by formula (I) below, or a pharmaceutically acceptable salt thereof, which, having histamine H3 receptor antagonist or inverse agonist activity, is useful in the prophylaxis or therapy of metabolic diseases, circulatory diseases, or nervous system diseases. [where, for example, Ar is a divalent group formed by eliminating two hydrogen atoms from benzene, X1 is a nitrogen atom, sulfur atom or oxygen atom, R1 is a 5- to 6-membered heteroaryl group, Ring A is a 5- to 6-membered heteroaryl ring, R2 and R3 are amino groups or alkylamino groups, and X2 is represented by formula (II): (where R4 and R5 are lower alkyl groups, and n is an integer from 2 to 4).]

  本发明提供了由下式（I）代表的化合物或其药学上可接受的盐，该化合物具有组胺 H3 受体拮抗剂或反向激动剂活性，可用于预防或治疗代谢性疾病、循环系统疾病或神经系统疾病。 [其中，Ar 是通过从苯中消除两个氢原子而形成的二价基团，X1 是氮原子、硫原子或氧原子，R1 是 5 至 6 元杂芳基，环 A 是 5 至 6 元杂芳基环，R2 和 R3 是氨基或烷基氨基，X2 由式 (II) 表示： (其中 R4 和 R5 为低级烷基，n 为 2 至 4 的整数）]。
• Chemo- and Diastereoselective Reduction of .beta.-Enamino Esters: A Convenient Synthesis of Both cis- and trans-.gamma.-Amino Alcohols and .beta.-Amino Esters
  作者：Giuseppe Bartoli、Cristina Cimarelli、Enrico Marcantoni、Gianni Palmieri、Marino Petrini

  DOI：10.1021/jo00097a039

  日期：1994.9

  Convenient procedures for the chemo- and diastereoselective reduction of beta-enamino esters 1 are described. Both cis- and trans-gamma-amino alcohols 2 or beta-amino esters 3 can be prepared by reduction of beta-enamino esters 1, readily available starting materials, with the use of inexpensive reagents Nali-PrOH or NaHbB(OAc)(3)/AcOH, respectively, and the appropriate reduction conditions. The mechanisms and diastereoselectivities for the reductions are discussed. The relative configurations and conformations of the diastereoisomeric gamma-amino alcohols 2 and beta-amino esters 3 obtained are established by H-1 and C-13 NMR study and unequivocally set by their cyclic derivatives tetrahydro-1,3-oxazines 4.